UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer

被引：0
|
作者：
Richardson, Debra [1 ]
Iyer, Gopa [2 ]
Schmid, Anita [3 ]
Palma, Norma [3 ]
Navarro, Willis [3 ]
Ahnert, Jordi Rodon [4 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Aadi Biosci, Pacific Palisades, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.424
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2126
引用
收藏
页码：S285 / S286
页数：2
相关论文
共 23 条
  • [21] A phase I study of the safety and pharmacokinetics of DNIB0600A, an anti-NaPi2b antibody-drug-conjugate (ADC), in patients (pts) with non- small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (OC).
    Gordon, Michael S.
    Gerber, David E.
    Infante, Jeffrey R.
    Xu, Jian
    Shames, David S.
    Choi, Younjeong
    Kahn, Robert S.
    Lin, Kedan
    Wood, Katie
    Maslyar, Daniel J.
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Maturing safety and activity profile from the FORWARD II phase 1b study.
    O'Malley, David M.
    Martin, Lainie P.
    Gilbert, Lucy
    Vergote, Ignace
    Matulonis, Ursula A.
    Birrer, Michael J.
    Castro, Cesar Martin
    Malek, Karim S.
    Gonzalez-Martin, Antonio
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
    Bardia, A.
    Messersmith, W. A.
    Kio, E. A.
    Berlin, J. D.
    Vahdat, L.
    Masters, G. A.
    Moroose, R.
    Santin, A. D.
    Kalinsky, K.
    Picozzi, V
    O'Shaughnessy, J.
    Gray, J. E.
    Komiya, T.
    Lang, J. M.
    Chang, J. C.
    Starodub, A.
    Goldenberg, D. M.
    Sharkey, R. M.
    Maliakal, P.
    Hong, Q.
    Wegener, W. A.
    Goswami, T.
    Ocean, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 746 - 756
123